Clinical Trials Browser

Interventional × linrodostat × Gastrointestinal × Clear all

NCT03695250 2023-08-22

BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer

Phase 1/2 Terminated

8 enrolled 11 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02935634 2023-06-09

FRACTION-GC

Phase 2 Completed

190 enrolled 25 charts

Gastrointestinal

Advanced Gastric Cancer